Vetter expands Development Service with a new location in Austria
- CDMO responds to increasing customer demand
- Investment in additional clinical filling capacities in Europe
- Planned commissioning in 2021
The biopharmaceutical development is increasingly focusing on highly specialized active ingredients. Pharmaceutical manufacturers are therefore more frequently…








